India receives 50,000 vials of anti-black fungus medicine from US pharma firms
US-based pharma firms like Gilead Sciences and Mylan have sent 50,000 vials of Amphotericin-B, the drug used for treating patients with black fungus, to India
India has received 50,000 vials of Amphotericin-B, the drug used for treating patients with black fungus, from US-based pharma firms like Gilead Sciences and Mylan on Friday
Black Fungus, also known as Mucormycosis has wreaked havoc across the country, especially in Covid-19 patients who have been administered heavy doses of steroids to treat the infection. Nearly 20 states have declared black fungus or mucormycosis as a notifiable disease under the Epidemic Diseases Act, 1897, including Delhi, Madhya Pradesh, Rajasthan, Uttarakhand, Tamil Nadu, and Bihar.
Mansukh Mandaviya, Minister of State for Chemicals and Fertilizers said that the ministry is putting in a lot of effort to meet the requirements of the drug in the country, after the increase in the cases of Black Fungus in the country.
The minister tweeted, "50,000 vials of #AmphotericinB arrives at Mumbai Airport. We are putting in a lot of efforts to meet its requirement in the country. I am thankful to @GileadSciences and @MylanNews for their outstanding support in India's fight against COVID-19".
Prime Minister Narendra Modi has instructed all concerned officials to arrange the drug from anywhere in the world on a war footing.
"The PM had instructed officials to get this drug from anywhere it is available in the world. Indian missions across the world have been involved in securing supplies of this drug. It has been achieved with help of Gilead Sciences in USA," the sources said.
Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
Business NewsNewsIndiaIndia receives 50,000 vials of anti-black fungus medicine from US pharma firms
First Published:28 May 2021, 06:13 PM IST
- Top Gainers
- Top Losers
- 52 Week High